Assessment of zolpidem and Cl-966 for anxiolytic and anxiogenic properties by using the discrimination of pentylenetetrazole by rats
- 1 January 1990
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 21 (3) , 243-252
- https://doi.org/10.1002/ddr.430210310
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Animal models of drug withdrawal symptomsPsychopharmacology, 1990
- Quantal vs. graded generalization in drug discrimination: measuring a graded responseJournal of Neuroscience Methods, 1990
- Neuropharmacological evidence for an interaction between the GABA uptake inhibitor Cl‐966 and anxiolytic benzodiazepinesDrug Development Research, 1990
- Does the pentylenetetrazole (PTZ) cue reflect PTZ‐induced kindling or PTZ‐induced anxiogenesis?Drug Development Research, 1989
- Diazepam tolerance and withdrawal assessed in an animal model of subjective drug effectsDrug Development Research, 1987
- High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptorsEuropean Journal of Pharmacology, 1986
- Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in ratsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Antagonism of discriminative stimuli produced by anxiogenic drugs as a novel approach to bioassay anxiolyticsDrug Development Research, 1984
- Behavioral analogues of anxiety animal modelsNeuropharmacology, 1983
- Drug Induced Discriminable Stimuli: Past Research and Future PerspectivesPublished by Springer Nature ,1977